Study details
Enrolling now
Biomarkers Research in Anxiety for Validation and Efficacy
Boston Children's Hospital
NCT IDNCT06221176ClinicalTrials.gov data as of Apr 2026
Target enrollment
25
Study length
about 1.3 years
Ages
3–6
Locations
1 site in MA
What this study is about
Researchers are testing a treatment called 'Being Brave' to see if it can help children with autism or autism spectrum disorder. The trial will look at four different biomarkers, which are signs that show how well the treatment is working.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Being Brave
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Spence Preschool Anxiety Scale (SPAS) or Spence Anxiety Scale (SCAS) Parent Report
Body systems
Psychiatry / Mental Health